参考文献/References:
[1] 中华医学会内分泌学分会 .中国高尿酸血症与痛风诊疗指南 (2019)[J].中华内分泌代谢杂志， 2020， 36（1）：1-13. Chinese Society of Endocrinology Chinese Medical As-sociation. Guideline for the diagnosis and management of hyperuricemia and gout in China(2019) [J]. Chinese Journal of Endocrinology and Metabolism, 2020, 36（1）:1-13.
[2] BARDIN T, RICHETTE P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options[J]. BMC Medicine, 2017, 15(1): 123.
[3] 中华医学会 , 中华医学会杂志社 , 中华医学会全科医学分会 ,等 .痛风及高尿酸血症基层诊疗指南（2019年）[J]. 中华全科医师杂志 , 2020, 19(4): 293-303. Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of General Practice, Chinese Association of Gout Study, et al.Guideline for primary care of gout and hyperuricemia(2019) [J]. Chinese Journal of General Practitioners, 2020, 19(4): 293-303.
[4] 陈芳，李素梅．高尿酸血症对肾脏损害的研究进展 [J].临床与病理杂志 , 2016, 36（3）: 285-289. CHEN Fang, LI Sumei. The research progress of hyper-uricemia induces kidney diseases[J]. International Jour-nal of Pathology and Clinical Medicine, 2016,36(3): 285-289.
[5] BARSOUM R, EL-KHATIB M. Uric acid and Life on earth[J]. Journal of Advanced Research, 2017, 8(5): 471-474.
[6] DE BECKER B, BORGHI C, BURNIER M, et al. Uric acid and hypertension: a focused review and practical recommendations[J]. Journal of Hypertension, 2019, 37(5): 878-883.
[7] JOHNSON R J, SAUTIN Y Y, OLIVER W J, et al. Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society[J]. Journal of Comparative Physiology B, 2009, 179(1): 67-76.
[8] 张玄娥，曲伸．高尿酸血症的现代进化与多重性作用 -从炎症角度审视高尿酸血症 [J]．中华内分泌代谢杂志 , 2019, 35（8）:718-722. DOI: 10.3760/cma. j.issn.1000-6699.2019.08.013 ZHANG Xuane, QU Shen. Recognizing hyperuri-cemia from the viewpoint of the inflammation[J]. Chinese Journal of Endocrinology and Metabo-lism, 2019,35(8): 718-722. DOI: 10.3760/cma. j.issn.1000-6699.2019.08.013
[9] NDREPEPA G. Uric acid and cardiovascular disease[J]. Clinica Chimica Acta, 2018, 484:150-163.
[10] MUIESAN M L, AGABITI-ROSEI C, PAINI A, et al. Uric acid and cardiovascular disease: an update[J]. European Cardiology, 2016, 11(1): 54-59.
[11] RAHIMI-SAKAK F, MAROOFI M, RAHMANI J, et al. Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants[J]. BMC Cardiovascular Disorders, 2019, 19(1): 218.
[12] XIA Shuang, DENG Songbai, WANG Yang, et al. Clinical analysis of the risk factors of slow coronary .ow[J]. Heart and Vessels, 2011, 26(5): 480-486.
[13] PATETSIOS P, SONG M, SHUTZE W P, et al. Identification of uric acid and xanthine oxidase in atherosclerotic plaque[J]. The American Journal of Cardiology, 2001, 88(2): 188-191, A6.
[14] BORGHI C, TYKARSKI A, WIDECKA K, et al. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk[J]. Cardiology Journal, 2018, 25(5): 545-563.
[15] 郭长磊 .冠脉造影与双源冠脉 CTA在诊断冠脉狭窄程度的价值研究 [J].中国 CT和 MRI杂志 ,2019,17（2）:12-14,24. GUO Changlei. Value of coronary angiography and dualsource coronary CTA in the diagnosis of coronary artery stenosis[J]. Chinese Journal of CT and MRI, 2019, 17(2): 12-14,24.
[16] 刘华，陈子平，刘奕然．血尿酸、血清同型半胱氨酸与冠状动脉病变程度的关系分析 [J]．中国老年保健医学 , 2020, 18（2）: 22-24. LIU Hua, CHEN Ziping, LIU Yiran. Relationship between serum homocysteine and serum uric acid and severity of coronary artery disease in patients with coronary heart disease[J]. Chinese Journal of Geriatric Care, 2020, 18( 2): 22-24.
[17] 唐宝华，李朝晖．血尿酸水平与冠状动脉病变严重程度的相关性分析 [J]．心脑血管病防治， 2011，11（4）：302-304． TANG Baohua ,LI Zhaohui. Analysis of correlation between serum uric acid level and severity of coronary artery disease [J]. Prevention and Treatment of Cardio-Cerebral-Vascular Disease, 2011, 11(4): 302-304.
[18] GUO Guofeng, HUANG Zhaoqi, WANG Shixiang, et al. Sex differences in uric acid and NT-pro BNP assessments during coronary severity[J]. Medicine, 2020, 99(15): e19653.
[19] HUANG He, HUANG Baotao, LI Yulin, et al. Uric acid and risk of heart failure: a systematic review and meta-analysis[J]. European Journal of Heart Failure, 2014, 16(1): 15-24.
[20] KANBAY M, AFSAR B, SIRIOPOL D, et al. Effect of uric Acid-Lowering agents on cardiovascular outcome in patients with heart failure: a systematic review and Meta-Analysis of clinical studies[J]. Angiology, 2020, 71(4): 315-323.
[21] WANG Ji, QIN Tianqiang, CHEN Jianrong, et al. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies[J]. PLoS One, 2014,.9(12): e114259.
[22] WU Lei, HE Yao, JIANG Bin, et al. Association between serum uric acid level and hypertension in a Chinese elderly rural population[J]. Clinical and Experimental Hypertension, 2017, 39(6): 505-512.
[23] CICERO A F G, ROSTICCI M, FOGACCI F, et al. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects[J]. European Journal of Internal Medicine, 2017, 37: 38-42.
[24] DE BECKER B, BORGHI C, BURNIER M A. Uric acid and hypertension[J].Journal of Hypertension, 2019, 37(5): 878-883.
[25] LI Ling, YANG Chen, ZHAO Yuliang, et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis besed on observational cohort studies [J]. BNC Nephrol, 2014, 15:122.
[26] HSU C Y, IRIBARREN C, MCCULLOCH C E, et al. Risk factors for end-stage renal disease: 25-year follow-up[J]. Archives of Internal Medicine, 2009, 169(4): 342-350.
[27] TSAI C W, LIN S Y, KUO C C, et al. Serum uric acid and progression of kidney disease: a longitudinal analysis and Mini-Review[J]. PLoS One, 2017, 12(1): e0170393.
[28] XIA Xi, LUO Qimei, LI Bin, et al. Serum uric acid and mortality in chronic kidney disease: A systematic review and meta-analysis[J]. Metabolism-Clinical and Experimental, 2016, 65(9): 1326-1341.
[29] YANG Yanlang, ZHOU Wei, WANG Yuwei, et al. Gender-specific association between uric acid level and chronic kidney disease in the elderly health checkup population in China[J]. Renal Failure, 2019, 41(1): 197-203.
[30] SRIVASTAVA A, KAZE A D, MCMULLAN C J, et al. Uric acid and the risks of kidney failure and death in individuals with CKD[J]. American Journal of Kidney Diseases, 2018, 71(3): 362-370.
[31] UCHIDA S, KUMAGAI T, CHANG W X, et al. Time to target uric acid to retard chronic kidney disease progression[J]. Contributions to Nephrology, 2018, 192: 56-68.
[32] 刘丹丹 , 崔雯霞 ,胡云 ,等 .高尿酸血症对慢性肾脏病影响的研究进展 [J]．中国临床研究，2020，33（1）： 120-123. LIU Dandan, CUI Wenxia, HU Yun, et al.Progress in studies on the effects of hyperuricemia on chronic kidney disease [J]. Chinese Journal of Clinical Research, 2020, 33(1): 120-123.
[33] 章晓炎，盛虹，谢静远，等．高尿酸血症与老年慢性肾脏病患者肾功能的相关性研究 [J]．内科理论与实践，2020, 15(3): 161-166. ZHANG Xiaoyan, SHENG Hong, XIE Jingyuan, et al. The correlation between hyperuricemia and renal function in elderly chronic kidney disease patients [J]. Journal of Internal Medicine Concepts & Practice, 2020, 15(3): 161-166.
[34] 中国医师协会肾脏内科医师分会．中国肾脏疾病高尿酸血症诊治的实践指南 (2017版 )[J].中华医学杂志 , 2017, 97(25):1927-1936. Kidney Physician Branch of Chinese Medical Association.Chinese Guidelines for the diagnosis and treatment of hyperuricemia in renal diseases (2017 edition)[J]. Chinese Journal of Medicine, 2017, 97(25):1927-1936.
[35] RYU E S, KIM M J, SHIN H S, et al. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease[J]. American Journal of Physiology-Renal Physiology, 2013, 304(5): F471-F480.
[36] CHINI L, ASSIS L, LUGON J R. Relationship between uric acid levels and risk of chronic kidney disease in a retrospective cohort of Brazilian workers[J]. Brazilian Journal of Medical and Biological Research, 2017, 50(9): e6048.
[37] NACAK H, VAN DIEPEN M, QURESHI A R, et al. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease[J]. Nephrology, Dialysis, Transplantation, 2015, 30(12):2039-2045.
[38] BADVE S V, PASCOE E M, TIKU A, et al. Effects of allopurinol on the progression of chronic kidney disease[J]. The New England Journal of Medicine, 2020, 382(26): 2504-2513.
[39] KIMURA K, HOSOYA T, UCHIDA S, et al. Febux-ostat therapy for patients with stage 3 CKD and asymp-tomatic hyperuricemia: a randomized trial[J]. American Journal of Kidney Diseases, 2018, 72(6): 798-810.
[40] ABREU E, FONSECA M J, SANTOS A C. Association between hyperuricemia and insulin resistance[J]. Acta medica portuguesa, 2011, 24(Suppl 2):565-574.
[41] 李长贵 ,路杰 ,辛颖 .高尿酸血症对糖尿病并发症的影响及其防治 [J].中华糖尿病杂志 , 2015（9）:535-537. LI Changgui, LU Jie, XIN Ying .Effect of hyperurice-mia on diabetic complications and its prevention and treatment [J]. Chinese Journal of Diabetes, 2015(9): 535-537.
[42] 郝盼蕊，明洁，贾爱华，等．血尿酸水平与糖尿病前期的相关研究 [J]．中华糖尿病杂志， 2018， 10(1):77-81. HAO Panrui, MING Jie, JIA Aihua, et al. Correlations between serum uric acid levels and prediabetes[J]. Chi-nese Journal of Diabetes, 2018, 10(1): 77-81.
[43] ZHU Dandan, WANG Yunzhi, ZOU Chen, et al. The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway[J]. Biochemical and Biophysical Research Communications, 2018, 503(2): 921-929.
[44] 佘新平，郑志 .血清尿酸水平在 2型糖尿病患者视网膜病变发病中的预测作用 [J].临床眼科杂志， 2019, 27（3）:221-225. SHE Xinping, ZHENG Zhi. The role of serum uric acid level in the prediction of the development of retinopathy in patients with type 2 diabetes mellitus[J]. Journal of Clinical Ophthalmology, 2019, 27(3): 221-225.
[45] 李红艳 , 凌凯 , 徐月霞 , 等 .血清尿酸与糖尿病肾病的相关性 [J].中国老年学杂志 , 2019, 39（6）:1321-1323. LI Hongyan, LING Kai, XU Yuexia, et al .Relationship between serum uric acid and diabetic nephropathy [J]. Chinese Journal of Gerontology, 2019, 39(6): 1321-1323.
[46] KIANI J, HABIBI Z, TAJZIEHCHI A, et al. Association between serum uric acid level and diabetic peripheral neuropathy (A case control study)[J]. Caspian Journal of Internal Medicine, 2014, 5(1): 17-21.
[47] YE Xiao, CAO Ying, GAO Fang, et al. Elevated serum uric acid levels are Independent risk factors for diabetic foot ulcer in female Chinese patients with type 2 diabetes[J]. Journal of Diabetes, 2014, 6(1): 42-47.
[48] BOEHNCKE W H, SCH.N M P. Psoriasis[J]. Lancet (London, England), 2015, 386(9997): 983-994.
[49] DUBERTRET L, MROWIETZ U, RANKI A, et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey[J]. The British Journal of Dermatology, 2006, 155(4): 729-736.
[50] LEA W J, CURTIS A C, BERNSTEIN I A. Serum uric acid levels in psoriasis[J]. The Journal of Investigative Dermatology, 1958, 31(5): 269-271.
[51] MOUSTAFA Y M, ELSAIED M A, ABD-ELAATY E M, et al. Evaluation of serum adenosine deaminase and inflammatory markers in psoriatic patients[J]. Indian Journal of Dermatology, 2019, 64(3): 207-212.
[52] GISONDI P, TARGHER G, CAGALLI A, et al. Hyper-uricemia in patients with chronic plaque psoriasis[J]. Journal of the American Academy of Dermatology, 2014, 70(1): 127-130.
[53] JAIN V K, LAL H. C-reactive protein and uric Acid levels in patients with psoriasis[J]. Indian Journal of Clinical Biochemistry, 2011, 26(3): 309-311.
[54] LI Xin, MIAO Xiao, WANG Hongshen. Association of serum uric acid levels in psoriasis[J]. Medicine, 2016, 95(19): e3676.
[55] LAI T L, YIM C W, WONG P Y, et al. Hyperuricemia in Asian psoriatic arthritis patients[J]. International Journal of Rheumatic Diseases, 2018, 21(4): 843-849.
[56] TANA C, TICINESI A, PRATI B, et al. Uric acid and cognitive function in older individuals[J]. Nutrients, 2018, 10(8): 975.
[57] YE B S, LEE W W, HAM J H, et al. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer’s disease biomarker related cognitive decline[J]. European Journal of Neurology, 2016, 23(5): 948-957.
[58] GONG Li, ZHANG Qilin, ZHANG Ning, et al. Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson’s disease: linking to Akt/GSK3β signaling pathway[J]. Journal of Neurochemistry, 2012, 123(5): 876-885.
[59] HUANG Tingting, HAO Donglin, WU Bona, et al. Uric acid demonstrates neuroprotective effect on Parkinson’s disease mice through Nrf2-ARE signaling pathway[J]. Biochemical and Biophysical Research Communications, 2017, 493(4): 1443-1449.
[60] SU Zhongqian, CHEN Zhibo, XIANG Yian, et al. Low serum levels of uric acid and albumin in patients with Guillain-Barre syndrome[J]. Medicine, 2017, 96(15): e6618.
[61] LEI Zhihao, CAI Jingjing, HONG Hua. Serum uric acid level and outcome of patients with ischemic stroke[J]. The Neurologist, 2019, 24(4): 121-131.
[62] SEET R C, KASIMAN K, GRUBER J, et al. Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study[J]. Atherosclerosis, 2010, 209(1): 215-219.